Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma

Published:2016-04 Issue:2 Volume:26 Page:202-204
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Kong Benjamin Y.,Micklethwaite Kenneth P.,Swaminathan Sanjay,Kefford Richard F.,Carlino Matteo S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference13 articles.

1. Ipilimumab-induced autoimmune pancytopenia in a case of metastatic melanoma.;du Rusquec;J Immunother,2014

2. Immune-mediated red cell aplasia after anti-CTLA-4 immunotherapy for metastatic melanoma.;Gordon;Cancer Immunol Immunother,2009

3. . Serious haematological toxicity during and after ipilimumab treatment: a case series.;Simeone;J Med Case Rep,2014

4. . In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates.;Wang;Cancer Immunol Res,2014

5. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.;Agata;Int Immunol,1996

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case report;Frontiers in Immunology;2024-03-20

2. Drug-induced immunotoxicity;Public Health and Toxicology Issues Drug Research, Volume 2;2024

3. Case Report: Life-threatening pancytopenia with tislelizumab followed by cerebral infarction in a patient with lung adenocarcinoma;Frontiers in Immunology;2023-07-25

4. Atezolizumab-Induced Direct Antiglobulin Test-Negative Autoimmune Hemolytic Anemia;American Journal of Therapeutics;2023-07-11

5. Hematological toxicities of immune checkpoint inhibitors and the impact of blood transfusion and its microbiome on therapeutic efficacy and recipient’s safety and survival outcome:A systematic narrative appraisal of where we are now!;Transfusion and Apheresis Science;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3